| Not Yet Recruiting | PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis NCT06956482 | University Hospital, Lille | Phase 3 |
| Not Yet Recruiting | A-TANGO Phase 2 Study NCT06890039 | Yaqrit Ltd | Phase 2 |
| Recruiting | Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease NCT07060547 | HepQuant, LLC | — |
| Recruiting | Short Course Steroids in Alcohol Associated Hepatitis NCT06919458 | Asian Institute of Gastroenterology, India | Phase 3 |
| Not Yet Recruiting | Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis NCT06789315 | Institute of Liver and Biliary Sciences, India | N/A |
| Not Yet Recruiting | Nutritional Interventions in Patients With Alcohol-associated Hepatitis NCT06131177 | Western University, Canada | N/A |
| Not Yet Recruiting | MRG-001 in Patients With Alcoholic Hepatitis NCT06307522 | MedRegen LLC | Phase 2 |
| Recruiting | Intra-Hepatic Microbiota in Alcoholic Hepatitis NCT06307964 | Hospices Civils de Lyon | — |
| Not Yet Recruiting | Complex Exploratory Study of Alcohol-Associated Hepatitis NCT06358196 | Pavol Jozef Safarik University | — |
| Unknown | Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discri NCT06355726 | Institute of Liver and Biliary Sciences, India | N/A |
| Recruiting | Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis NCT05006430 | Prasun Kumar Jalal | Phase 1 / Phase 2 |
| Recruiting | Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Al NCT05294744 | Bioaraba Health Research Institute | N/A |
| Recruiting | HA35 Moderate Alcoholic Hepatitis (AH) Study NCT05018481 | The Cleveland Clinic | EARLY_Phase 1 |
| Unknown | BActeriophages To Treat Liver Disease Eliminating Harmful Bacteria (BATTLE) NCT05618418 | Copenhagen University Hospital, Hvidovre | — |
| Unknown | Fecal Microbiota Therapy in Steroid Ineligible Alcoholic Hepatitis NCT05285592 | Institute of Liver and Biliary Sciences, India | N/A |
| Withdrawn | CytoSorb® in Patients With Acute on Chronic Liver Failure NCT05131230 | CytoSorbents Europe GmbH | — |
| Completed | DUR-928 in Patients With Alcoholic Hepatitis NCT03917407 | Craig James McClain | Phase 2 |
| Unknown | Outcomes Using MARS for Patients With ALF NCT05594953 | Methodist Health System | — |
| Completed | A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment NCT04563026 | Durect | Phase 2 |
| Recruiting | Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH NCT03845205 | Johns Hopkins University | N/A |
| Completed | Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis NCT04072822 | Indiana University | Phase 2 |
| Withdrawn | Immunology of HIV and Alcoholic Hepatitis NCT03951662 | Indiana University | — |
| Completed | EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication? NCT04235855 | Asian Institute of Gastroenterology, India | N/A |
| Recruiting | Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic H NCT04088370 | The Cleveland Clinic | — |
| Completed | Effect of Saturated Fat (Desi Ghee) on Gut-Liver Axis in Alcoholic Hepatitis NCT04084522 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Pati NCT04066179 | Institute of Liver and Biliary Sciences, India | N/A |
| Completed | Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis) NCT04544020 | University of Aberdeen | — |
| Completed | Alcoholic Hepatitis Network Observational Study NCT03850899 | Indiana University | — |
| Completed | Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis NCT03829683 | Virginia Commonwealth University | Phase 2 |
| Completed | IL-1 Signal Inhibition in Alcoholic Hepatitis NCT03775109 | Imperial College London | Phase 2 |
| Completed | Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic Hepatiti NCT03732586 | Hospital General Dr. Manuel Gea González | N/A |
| Completed | A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoh NCT03432260 | Durect | Phase 2 |
| Unknown | Fecal Microbial Transplantation in Severe Alcoholic Hepatitis NCT04758806 | F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica | Phase 3 |
| Unknown | Corticosteroids in Alcoholic Hepatitis NCT03160651 | Erasme University Hospital | N/A |
| Unknown | GCSF in Alcoholic Hepatitis NCT03703674 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 |
| Active Not Recruiting | Gut-Liver Axis Modulation With IgG-Enriched Immunotherapy in Severe Alcohol-Associated Hepatitis NCT02473341 | Dayanand Medical College and Hospital | Phase 3 |
| Completed | Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis NCT05840640 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 |
| Completed | Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults NCT03149627 | University of Alabama at Birmingham | — |
| Completed | Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis. NCT05883891 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Completed | The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis. NCT03157388 | University of Aarhus | N/A |
| Completed | Pegfilgrastim in Patients With Alcoholic Hepatitis NCT02776059 | Timothy Morgan, MD | Phase 2 |
| Active Not Recruiting | Chronic Hepatitis B Virus Infection in Zambia NCT03158818 | University of Alabama at Birmingham | — |
| Completed | Use of F-652 in Patients With Alcoholic Hepatitis NCT02655510 | Mayo Clinic | Phase 1 / Phase 2 |
| Unknown | N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis NCT03069300 | Imperial College London | Phase 3 |
| Active Not Recruiting | Liver Fibrosis in Zambian HIV-HBV Co-infected Patients NCT02344680 | University of Alabama at Birmingham | — |
| Terminated | Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Ster NCT02442180 | Chuncheon Sacred Heart Hospital | Phase 3 |
| Completed | Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone NCT02281929 | University Hospital, Lille | Phase 3 |
| Completed | Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis NCT02796469 | University Hospital, Lille | — |
| Completed | Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis NCT02326103 | University of Helsinki | EARLY_Phase 1 |
| Completed | A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis NCT01903798 | Southern California Institute for Research and Education | Phase 2 |
| Completed | Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis NCT02458079 | Institute of Liver and Biliary Sciences, India | N/A |
| Terminated | Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH) NCT02039219 | Naga P. Chalasani | Phase 2 |
| Unknown | G-CSF Plus NAC In Severe Alcoholic Hepatitis NCT02971306 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 |
| Completed | Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis NCT02075918 | University of Pittsburgh | — |
| Terminated | Study of IDN-6556 in Patients With Severe Alcoholic Hepatitis and Contraindications to Steroid Therapy NCT01912404 | Conatus Pharmaceuticals Inc. | Phase 2 |
| Completed | Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium NCT02172898 | Indiana University | — |
| Unknown | Effects of Rifaximin in Patients With Acute Alcoholic Hepatitis NCT02116556 | Hospital Universitari Vall d'Hebron Research Institute | Phase 2 |
| Completed | Protective Immune Mechanisms in Alcoholic Hepatitis NCT01918462 | University of Aarhus | — |
| Suspended | Liver Transplantation in Alcoholic Hepatitis NCT01768715 | Sociedad Española de Trasplante Hepático | — |
| Completed | Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatme NCT01756794 | University Hospital, Lille | N/A |
| Completed | Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis NCT01245257 | University of Aarhus | — |
| Completed | Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis NCT02019056 | PharmaKing | Phase 2 |
| Completed | Prognostic Indicators as Provided by the EPIC ClearView NCT01476995 | Epic Research & Diagnostics, Inc. | — |
| Completed | Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis NCT00992888 | University of Aarhus | N/A |
| Unknown | Short-term Survival in Patients With Severe Alcoholic Hepatitis Treated With Steroid Versus Pentoxifylline NCT01455337 | Inje University | Phase 3 |
| Completed | Randomized, Controlled Trial of S-adenosylmethionine in Alcoholic Liver Disease NCT00851981 | Loma Linda University | Phase 2 |
| Completed | Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis NCT01214226 | University Hospital, Lille | Phase 3 |
| Completed | Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human NCT00388323 | Assistance Publique - Hôpitaux de Paris | N/A |
| Withdrawn | Treatment of Alcohol-Related Hepatitis With Arginine NCT00200746 | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
| Completed | Treatment of Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone NCT00863785 | Centre Hospitalier Universitaire, Amiens | Phase 3 |
| Completed | N-Acetylcysteine in Severe Acute Alcoholic Hepatitis NCT00962442 | Erasme University Hospital | Phase 3 |